These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36929083)

  • 1. Pharmacogenomic and Statistical Analysis.
    Bai H; Zhang X; Bush WS
    Methods Mol Biol; 2023; 2629():305-330. PubMed ID: 36929083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
    Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards the integration of pharmacogenomics in practice.
    Mooney SD
    Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Tayeh MK; Gaedigk A; Goetz MP; Klein TE; Lyon E; McMillin GA; Rentas S; Shinawi M; Pratt VM; Scott SA;
    Genet Med; 2022 Apr; 24(4):759-768. PubMed ID: 35177334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
    Tseng AS; Patel RD; Quist HE; Kekic A; Maddux JT; Grilli CB; Shamoun FE
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):121-126. PubMed ID: 29435777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.
    Pandi MT; Williams MS; van der Spek P; Koromina M; Patrinos GP
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in Cardiovascular Diseases.
    McDonough CW
    Curr Protoc; 2021 Jul; 1(7):e189. PubMed ID: 34232575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group.
    Srinivasan BS; Chen J; Cheng C; Conti D; Duan S; Fridley BL; Gu X; Haines JL; Jorgenson E; Kraja A; Lasky-Su J; Li L; Rodin A; Wang D; Province M; Ritchie MD
    Pharmacogenomics; 2009 Feb; 10(2):243-51. PubMed ID: 19207025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics: introduction and use in clinical practice.
    Saunders H; Harris D; Chirilă RM
    Rom J Intern Med; 2020 Jun; 58(2):69-74. PubMed ID: 32074077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?
    Lopes JL; Harris K; Karow MB; Peterson SE; Kluge ML; Kotzer KE; Lopes GS; Larson NB; Bielinski SJ; Scherer SE; Wang L; Weinshilboum RM; Black JL; Moyer AM
    J Mol Diagn; 2022 Mar; 24(3):253-261. PubMed ID: 35041929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations When Applying Pharmacogenomics to Your Practice.
    Nicholson WT; Formea CM; Matey ET; Wright JA; Giri J; Moyer AM
    Mayo Clin Proc; 2021 Jan; 96(1):218-230. PubMed ID: 33308868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.